LIPO-C — sometimes labeled a “Fat Blaster” — is a lipotropic injectable blend, not a single peptide. That’s worth stating plainly up front: unlike most compounds in this library, LIPO-C is a combination of nutrients rather than a signaling peptide.
What you’re reading about
“Lipotropic” means “fat-metabolizing.” A typical LIPO-C formula combines methionine, inositol, and choline — together abbreviated MIC — usually with L-carnitine and B-vitamins. Each is a nutrient the body already uses in fat and energy metabolism.
The components
- Methionine — an essential amino acid involved in lipid processing.
- Inositol — a sugar alcohol involved in cell signaling.
- Choline — a nutrient essential to how the liver transports fat.
- L-carnitine — shuttles fatty acids into mitochondria to be burned for energy.
Research outlook
The honest picture: while each individual nutrient has an established role in metabolism, rigorous clinical evidence for lipotropic injections as a combined fat-loss treatment is limited. The components are best understood through their own nutritional science, and well-controlled trials of the blend itself remain sparse — a genuine gap where better research is needed.
References
- TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
- Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway
- Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis
- Dietary choline, but not L-carnitine, increases circulating lipid and lipoprotein concentrations, without affecting body composition, energy expenditure or respiratory quotient in lean and obese male cats during weight maintenance
- Choline and methionine differentially alter methyl carbon metabolism in bovine neonatal hepatocytes
